REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 202,180 Value ($000) $615 Avg Close Range
Q3 2024
Shares 203,200 Value ($000) $1,055 Avg Close Range
Q2 2019
Shares 1,880 Value ($000) $24 Avg Close Range
Q3 2018
Shares 200 Value ($000) $5 Avg Close Range
Q1 2018
Shares 12,970 Value ($000) $399 Avg Close Range
Q4 2017
Shares 16,982 Value ($000) $607 Avg Close Range
Q3 2017
Shares 10,233 Value ($000) $282 Avg Close Range
Q2 2017
Shares 16,125 Value ($000) $426 Avg Close Range
Q1 2017
Shares 3,576 Value ($000) $74 Avg Close Range
Q4 2015
Shares 1,300 Value ($000) $44 Avg Close Range